Valink Therapeutics, a biopharmaceutical company focused on discovering and developing innovative bispecific antibody-drug conjugates (bsADCs) to transform the treatment of cancer and other diseases, ...
PCM receives funding from the Francis Crick Institute (CC2223); University College London Hospitals National Institute for Health and Care Research Biomedical Research Centre; and has received funding ...